Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if C16G2 Gel administered over a certain period of
time either with a toothbrush or a custom dental tray can effectively kill bacteria in the
mouth that cause dental cavities.
Phase:
Phase 2
Details
Lead Sponsor:
Armata Pharmaceuticals, Inc. C3 Jian, Inc.
Collaborators:
Agility Clinical, Inc. SynteractHCR Vantage Data Designs, Inc.